Clicky

CAPRICOR THERAP. DL-001(4LN2) News

Date Title
Jan 3 CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA
Jan 2 Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy